Celtrix Pharmaceuticals, Inc.
Records under this name other than patents Celtrix Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Celtrix Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,040,292 | Methods for treating diabetes Term ended Term ended Jun 4, 2019 · From the USPTO record | Term ended | Term ended Jun 4, 2019 | From the USPTO record |
| US 6,417,330 | Insulin-like growth factor binding protein variants Term ended Term ended May 27, 2019 · From the USPTO record | Term ended | Term ended May 27, 2019 | From the USPTO record |
| US 6,436,897 | Pharmaceutical formulations for IGF/IGFBP Term ended Term ended Jun 1, 2018 · From the USPTO record | Term ended | Term ended Jun 1, 2018 | From the USPTO record |
| US 6,514,937 | Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 Term ended Term ended Feb 25, 2017 · From the USPTO record | Term ended | Term ended Feb 25, 2017 | From the USPTO record |
| US 6,518,238 | Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 Term ended Term ended Feb 25, 2017 · From the USPTO record | Term ended | Term ended Feb 25, 2017 | From the USPTO record |
| US 6,124,259 | Method for treating ophthalmic disorders with IGFBP Lapsed on the fee record Ended Sep 26, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 26, 2012 | From the USPTO record |
| US 6,025,332 | Method for treating low circulating levels of sex hormone steroids associated with aging using IGF or IGF/IGFBP-3 Lapsed on the fee record Ended Feb 15, 2012 · From the USPTO record | Lapsed on the fee record | Ended Feb 15, 2012 | From the USPTO record |
| US 6,025,368 | Method for treating the symptoms of chronic stress-related disorders using IGF Lapsed on the fee record Ended Feb 15, 2012 · From the USPTO record | Lapsed on the fee record | Ended Feb 15, 2012 | From the USPTO record |
| US 6,685,930 | Methods and substances for recruiting therapeutic agents to solid tumors Formerly held Lapsed on the fee record Ended Feb 3, 2012 · From the USPTO record | Lapsed on the fee record | Ended Feb 3, 2012 | From the USPTO record |
| US 6,017,885 | IGF/IGFBP complex for promoting bone formation and for regulating bone remodeling Lapsed on the fee record Ended Jan 25, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jan 25, 2012 | From the USPTO record |